Scinai Immunotherapeutics Ltd (SCNI) Live Share Price, Invest From India

Scinai Immunotherapeutics Ltd Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
Day's High
$0.68
Day's Price Range
$0.74
$0.71
4.23%
Downside
4.23%
Upside
52 Week's Low
52 Week's High
$0.45
52-Week Price Range
$6.18
$0.71
35.93%
Downside
770.42%
Upside

Scinai Immunotherapeutics Ltd share price movements today

Previous Close: $0.74
Open: $0.69
Volume: 437.2K
Day's Low - High: $0.68 - $0.74
52 Week Low - High: $0.45 - $6.18

Scinai Immunotherapeutics Ltd Historical Returns

1 Month Return: + 18.33 %
3 Month Return: -28.28 %
1 Year Return: -74.46 %
3 Year Return: 0 %
5 Year Return: 0 %

Scinai Immunotherapeutics Ltd Stock Fundamentals & Key Indicators

Check Scinai Immunotherapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.6M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.87%

PE Ratio (TTM)

PEG Ratio

EBITDA

-6.1M

Revenue (TTM)

1.3M

Profit Margin

0.00%

Return On Equity TTM

-91.89%

Scinai Immunotherapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Scinai Immunotherapeutics Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Scinai Immunotherapeutics Ltd	BUY	$2.6M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for Scinai Immunotherapeutics Ltd Stock including INR - Dollar returns

The Scinai Immunotherapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Scinai Immunotherapeutics Ltd investment value today

Current value as on today

₹28,756

Returns

-₹71,244

(-71.24%)

Returns from Scinai Immunotherapeutics Ltd Stock

-₹74,460 (-74.46%)

Dollar Impact

₹3,216 (+3.22%)

Analyst Recommendation on Scinai Immunotherapeutics Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Scinai Immunotherapeutics Ltd. Average target price of $700

Scinai Immunotherapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Scinai Immunotherapeutics Ltd.

What analysts predicted

99.9%UPSIDE

Target Price

$700

Current Price

$0.71

Analyzed by

7 Analysts

Target

$700.00

Scinai Immunotherapeutics Ltd target price $700, a slight upside of 99.9% compared to current price of $0.71. According to 7 analysts rating.

Scinai Immunotherapeutics Ltd Stock’s Investor Sentiment and Interest

Investment in Scinai Immunotherapeutics Ltd Shares on INDmoney has grown by 3675.00% over the past 30 days, indicating increased transactional activity.

Time period: April 4, 2026 to May 4, 2026

Change:3675.00% versus previous 30 day period

Search interest for Scinai Immunotherapeutics Ltd Stock has increased by 1911% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 4, 2026 to May 4, 2026

Change:1911% versus previous 30 day period

Scinai Immunotherapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Total Revenue	-	-	-	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	-	-1
Operating Income	-2	-1	-2	3	-2	-2	-1	-1	0	-2
EBITDA	-1	-1	-1	-1	12	-	0	-1	0	-3
Interest Expense	0	0	0	0	1	0	0	0	-	0
Depreciation	0	0	0	0	0	0	-	-	-	-
Income Before Tax	3	-2	-2	-2	10	-2	-2	-2	-	-4
Income Tax Expense	0	0	0	0	-	-	-	-	-	-
Net Income	3	-2	-2	-2	10	-2	-2	-2	-2	-2
Net Profit Margin	0.00%	0.00%	0.00%	-817.61%	6223.21%	-1082.52%	-534.80%	-534.80%	-764.49%	-778.78%

Scinai Immunotherapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	0	1
Gross Profit	-	0	0	0	0	0	-2
Operating Income	-22	2	-10	-11	-9	-8	-7
EBITDA	-22	2	-10	-10	-9	-6	-6
Interest Expense	4	0	3	5	0	1	0
Depreciation	1	2	2	0	0	1	1
Income Before Tax	-31	-1	-8	-5	-6	4	-8
Income Tax Expense	14	-26	3	0	-	-	-
Net Income	-31	-1	-8	-5	-6	4	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	728.88%	-633.64%

Scinai Immunotherapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	3	-2	-2	-2	10	-2	-2	-2
Operating Cash Flow	-2	-2	-1	-1	-1	-2	-1	-1	-1
Investing Cash Flow	0	0	0	0	0	0	-	0	0
Financing Cash Flow	-	1	0	1	0	0	2	0	0
Change in Cash	-3	-1	-1	0	-1	-2	0	-2	-

Scinai Immunotherapeutics Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-23	-31	-1	-8	-5	-6	4	-8
Operating Cash Flow	-2	-15	-22	-22	-7	-7	-9	-6	-6
Investing Cash Flow	1	-6	-2	-1	0	0	0	0	0
Financing Cash Flow	17	22	24	4	21	6	1	3	5
Change in Cash	16	0	0	-18	14	-3	-9	-2	0

Insights on Scinai Immunotherapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, SCNI stock has moved up by 18.3%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 90.3%

About Scinai Immunotherapeutics Ltd

Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel. It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis. The company also provides contract development and manufacturing organization services to biotech companies. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody. The company has a strategic collaboration with Recipharm Israel Ltd for the development of Lifecycle CDMO Platform. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Organisation	Scinai Immunotherapeutics Ltd
Headquarters	Jerusalem BioPark, Jerusalem, Israel
Industry	Biotechnology
CEO	Mr. Amir Reichman M.B.A., M.Sc.
E-voting on shares	Click here to vote

Key Management of Scinai Immunotherapeutics Ltd

Name	Title
Gal Ron	Head of HR
Merav Kamensky	Head of Quality Control & GMP Analytics
Dr. Naama Adi Hen	Head of Quality Asurance
Tehila Sonnenfeld	Head of Manufacturing
Mr. Amir Reichman M.B.A., M.Sc.	CEO & Director
Mr. Uri Ben-Or CPA, M.B.A.	Chief Financial Officer
Mr. Elad Mark B.Sc., Eng., M.B.A.	Chief Operating Officer

FAQs

What is Scinai Immunotherapeutics Ltd share price today?

Scinai Immunotherapeutics Ltd share price today is $0.71 as on May 2, 2026 at 1:29 am IST at the close of the market. Scinai Immunotherapeutics Ltd share today touched a day high of $0.74 and a low of $0.68.

What is the 52 week high and 52 week low for Scinai Immunotherapeutics Ltd share?

Scinai Immunotherapeutics Ltd share touched a 52 week high of $6.18 on June 5, 2025 and a 52 week low of $0.45 on April 23, 2026. Scinai Immunotherapeutics Ltd stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $0.71,which is 88.51% down from its 52 week high and 56.08% up from its 52 week low.

What is Scinai Immunotherapeutics Ltd's market capitalisation today?

Scinai Immunotherapeutics Ltd market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in Scinai Immunotherapeutics Ltd Stock (SCNI) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Scinai Immunotherapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Scinai Immunotherapeutics Ltd Shares that will get you 2.1127 shares as per Scinai Immunotherapeutics Ltd share price of $0.71 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Scinai Immunotherapeutics Ltd Stock (SCNI) from India?

Indian investors can start investing in Scinai Immunotherapeutics Ltd (SCNI) shares with as little as ₹94.91 or $1 (as of May 4, 2026 at 8:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Scinai Immunotherapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on May 4, 2026 at 8:42 am IST). Based on Scinai Immunotherapeutics Ltd share’s latest price of $0.71 as on May 2, 2026 at 1:29 am IST, you will get 14.0845 shares of Scinai Immunotherapeutics Ltd. Learn more about fractional shares .